David Gray
Has grant
Chief Science Officer
United StatesResearch Interests
Explore related searches
Contact this professor
Get a free first email built on one of their papers, ready for you to edit and send yourself.
About
David Gray is the Chief Science Officer at Vigil Neuroscience Inc, located in the United States. His research areas encompass the mechanisms of dopamine receptor stimulation in relation to neurological disorders, particularly in Parkinson's disease and schizophrenia. Recent publications focus on the development of novel dopamine agonists and their cognitive effects, as well as the economic impact of Parkinson's disease among Medicare beneficiaries.
Recent Grants
Grant: Close
Combating opioid addiction using CVL-936, a novel D3/D2 receptor antagonist
Open Date: 2021-04-15
Close Date: 2024-03-31
Grant: Close
A Translational and Neurocomputational Evaluation of a D1R Partial Agonist for Schizophrenia
Open Date: 2019-09-23
Close Date: 2023-08-31
Grant: Close
A Program for Innovative PET Radioligand Development and Application - atranslational toolbox for treatments for Mental Health
Open Date: 2015-09-24
Close Date: 2023-06-30
Articles (10)
Year:
2023
Year:
2022
Year:
2021
Year:
2021
Year:
2021
Year:
2021
Year:
2020
Year:
2020
Year:
2020
Year:
2020
Collaborators (2)
Youngsun Cho
Assistant Professor
Yale University
Vinod Srihari
Professor
Yale University School of Medicine
ApplyKite TwinLearns as you applyMake your next move.
Prepare your application
Review drafts before you send them.